{ "ticker": "HCA", "cik": "0000860730", "company": "HCA Healthcare, Inc.", "business_type": "healthcare", "schema_template": "Hospital operator (health care services). The income statement follows HCA's own layout: revenues, then each cost line it prints (salaries and benefits, supplies, other operating expenses, equity in earnings of affiliates, depreciation and amortization, interest expense, losses or gains on sales of facilities), total costs and expenses, income before income taxes, taxes, net income, the share attributable to noncontrolling interests and to HCA Healthcare, Inc., and basic and diluted EPS with weighted shares. HCA prints no cost of revenue, gross profit or operating income line, so none is shown. The balance sheet, cash flow and equity-statement items follow the statements' own captions. Non-GAAP measures (Adjusted EBITDA, adjusted EPS) and hospital operating statistics (admissions, equivalent admissions, same-facility growth) come from the quarterly earnings release, because they are how the company itself measures a hospital business.", "reporting_currency": "USD", "converted_to_usd": false, "units": "actual US dollars (not millions); per-share amounts in dollars; share counts in actual shares; operating statistics in actual counts (revenue per equivalent admission in dollars); fields ending _pct are percentages (19.7 means 19.7%)", "units_notes_seen": { "FY2025 10-K consolidated income statements": "(Dollars in millions, except per share amounts); share counts under 'Shares used in earnings per share calculations (in millions)'", "FY2025 10-K consolidated balance sheets": "(Dollars in millions); shares outstanding printed in actual shares in the common stock caption", "FY2025 10-K consolidated statements of stockholders' equity (deficit)": "(Dollars in millions, except per share amounts); share column '(in millions)'", "FY2025 10-K consolidated statements of cash flows": "(Dollars in millions)", "FY2025 10-K Note 8 Debt": "(dollars in millions)", "Q3 2026 10-Q condensed consolidated income statements": "(Dollars in millions, except per share amounts); share counts under 'Shares used in earnings per share calculations (in millions)'", "Q3 2026 10-Q condensed consolidated balance sheets": "(Dollars in millions); shares outstanding printed in actual shares in the common stock caption", "Q3 2026 10-Q condensed consolidated statements of stockholders' equity (deficit)": "(Dollars in millions); share column '(in millions)'", "Q3 2026 10-Q condensed consolidated statements of cash flows": "(Dollars in millions)", "Q3 2026 10-Q Note 7 Debt": "(dollars in millions)", "Q3 2026 earnings release, Supplemental Non-GAAP Disclosures": "(Dollars in millions, except per share amounts)", "Q3 2026 earnings release, Operating Statistics": "no units note; counts printed in actual units, revenue per equivalent admission in dollars, '% Change' rows in percent", "Q3 2026 and Q3 2025 earnings releases, cash flow sentences": "amounts stated in billions to three decimals (for example '$4.461 billion')" }, "adjustments": { "splits_applied": [], "adr_ratio": null, "fx": "none; HCA Healthcare reports in US dollars", "split_note": "No stock split affects these periods; per-share figures are as filed." }, "definitions": { "revenues": "the income statement's 'Revenues' line, the company's total top line", "salaries_and_benefits, supplies, other_operating_expenses, depreciation_and_amortization, interest_expense": "costs as printed in the income statement's costs and expenses section; positive = expense", "equity_in_earnings_of_affiliates, losses_gains_on_sales_of_facilities": "as printed within costs and expenses; a negative value is a credit that reduces total costs (earnings from affiliates, or a net gain on facility sales)", "total_costs_and_expenses": "the unlabelled subtotal of all cost lines above, which includes interest expense", "net_income": "consolidated net income, including the share attributable to noncontrolling interests", "net_income_attributable_to_hca_healthcare": "net income attributable to HCA Healthcare, Inc., the figure basic and diluted EPS are struck on", "basic_shares, diluted_shares": "weighted average shares used in the EPS calculation", "accumulated_depreciation, accumulated_other_comprehensive_loss, retained_deficit": "negative values, as the balance sheet prints them in parentheses", "stockholders_deficit_attributable_to_hca_healthcare, total_equity": "negative values are a deficit; total_equity includes noncontrolling interests", "total_liabilities": "computed here as the sum of the liability lines the balance sheet prints (total current liabilities, long-term debt, professional liability risks, lease obligations, and income taxes and other liabilities); the balance sheet prints no total-liabilities line", "total_debt": "the 'Total debt' line of the debt note: short-term borrowings and long-term debt due within one year plus long-term debt, net of debt issuance costs and discounts", "shares_outstanding": "common shares outstanding at the balance-sheet date, from the common stock caption", "capital_expenditures, acquisitions_of_hospitals_and_health_care_entities, repayment_of_long_term_debt, distributions_to_noncontrolling_interests, payment_of_dividends, repurchase_of_common_stock": "cash outflows stored as positive amounts paid (the cash flow statement prints them in parentheses)", "net_cash_from_investing_activities, net_cash_from_financing_activities, net_change_in_short_term_borrowings_and_revolving_credit_facilities, change_in_cash_and_cash_equivalents": "signed as the statement prints them; negative = net cash used", "free_cash_flow": "operating cash flow less capital expenditures (purchase of property and equipment), computed here; HCA does not report a free cash flow measure", "cash_dividends_declared, repurchase_of_common_stock_equity_statement, shares_repurchased": "from the statement of stockholders' equity (deficit), stored as positive amounts; the repurchase amount is the total charged to equity, which can differ from the cash paid shown in the cash flow statement", "non_gaap": "HCA's own non-GAAP measures, as printed in its earnings release. Adjusted EBITDA and the adjusted figures exclude losses (gains) on sales of facilities and losses on retirement of debt; Adjusted EBITDA margin is Adjusted EBITDA divided by revenues. They are not GAAP measures.", "operating_statistics": "hospital volume statistics from the earnings release. Same-facility growth rates compare the period with the same period a year earlier, so they are recorded on the current period only." }, "annual": [ { "fiscal_year": 2025, "label": "FY2025", "period_start": "2025-01-01", "period_end": "2025-12-31", "period_type": "fiscal year", "source_accession": "0001193125-26-044769", "income_statement": { "revenues": 75600000000, "salaries_and_benefits": 32859000000, "supplies": 11367000000, "other_operating_expenses": 15886000000, "equity_in_earnings_of_affiliates": -78000000, "depreciation_and_amortization": 3523000000, "interest_expense": 2248000000, "losses_gains_on_sales_of_facilities": -37000000, "total_costs_and_expenses": 65768000000, "income_before_income_taxes": 9832000000, "provision_for_income_taxes": 2050000000, "net_income": 7782000000, "net_income_attributable_to_noncontrolling_interests": 998000000, "net_income_attributable_to_hca_healthcare": 6784000000, "basic_eps": 28.7, "diluted_eps": 28.33, "basic_shares": 236413000, "diluted_shares": 239495000 }, "balance_sheet": { "cash_and_cash_equivalents": 1040000000, "accounts_receivable": 10867000000, "inventories": 1652000000, "other_current_assets": 2224000000, "total_current_assets": 15783000000, "property_and_equipment_at_cost": 66275000000, "accumulated_depreciation": -35134000000, "property_and_equipment_net": 31141000000, "investments_of_insurance_subsidiaries": 485000000, "investments_in_and_advances_to_affiliates": 633000000, "goodwill_and_other_intangible_assets": 10293000000, "right_of_use_operating_lease_assets": 2130000000, "other_assets": 255000000, "total_assets": 60720000000, "accounts_payable": 4659000000, "accrued_salaries": 2525000000, "other_accrued_expenses": 4277000000, "short_term_borrowings_and_long_term_debt_due_within_one_year": 4889000000, "total_current_liabilities": 16350000000, "long_term_debt": 41603000000, "professional_liability_risks": 1466000000, "right_of_use_operating_lease_obligations": 1853000000, "income_taxes_and_other_liabilities": 2219000000, "accumulated_other_comprehensive_loss": -305000000, "retained_deficit": -5724000000, "stockholders_deficit_attributable_to_hca_healthcare": -6027000000, "noncontrolling_interests": 3256000000, "total_equity": -2771000000, "total_debt": 46492000000, "shares_outstanding": 224605100, "total_liabilities": 63491000000 }, "cash_flow": { "operating_cash_flow": 12636000000, "depreciation_and_amortization": 3523000000, "share_based_compensation": 401000000, "capital_expenditures": 4944000000, "acquisitions_of_hospitals_and_health_care_entities": 397000000, "sales_of_hospitals_and_health_care_entities": 269000000, "net_cash_from_investing_activities": -4988000000, "issuances_of_long_term_debt": 8474000000, "net_change_in_short_term_borrowings_and_revolving_credit_facilities": 2202000000, "repayment_of_long_term_debt": 7389000000, "distributions_to_noncontrolling_interests": 827000000, "payment_of_dividends": 679000000, "repurchase_of_common_stock": 10067000000, "net_cash_from_financing_activities": -8550000000, "change_in_cash_and_cash_equivalents": -893000000, "interest_payments": 2207000000, "income_tax_payments_net": 1740000000, "free_cash_flow": 7692000000 }, "shareholder_returns": { "cash_dividends_declared": 684000000, "cash_dividends_declared_per_share": 2.88, "shares_repurchased": 26739000, "repurchase_of_common_stock_equity_statement": 10110000000 } }, { "fiscal_year": 2024, "label": "FY2024", "period_start": "2024-01-01", "period_end": "2024-12-31", "period_type": "fiscal year", "source_accession": "0001193125-26-044769", "income_statement": { "revenues": 70603000000, "salaries_and_benefits": 31170000000, "supplies": 10755000000, "other_operating_expenses": 14819000000, "equity_in_earnings_of_affiliates": -23000000, "depreciation_and_amortization": 3312000000, "interest_expense": 2061000000, "losses_gains_on_sales_of_facilities": -14000000, "total_costs_and_expenses": 62080000000, "income_before_income_taxes": 8523000000, "provision_for_income_taxes": 1866000000, "net_income": 6657000000, "net_income_attributable_to_noncontrolling_interests": 897000000, "net_income_attributable_to_hca_healthcare": 5760000000, "basic_eps": 22.27, "diluted_eps": 22, "basic_shares": 258603000, "diluted_shares": 261806000 }, "balance_sheet": { "cash_and_cash_equivalents": 1933000000, "accounts_receivable": 10751000000, "inventories": 1738000000, "other_current_assets": 1992000000, "total_current_assets": 16414000000, "property_and_equipment_at_cost": 62514000000, "accumulated_depreciation": -33100000000, "property_and_equipment_net": 29414000000, "investments_of_insurance_subsidiaries": 569000000, "investments_in_and_advances_to_affiliates": 662000000, "goodwill_and_other_intangible_assets": 10093000000, "right_of_use_operating_lease_assets": 2131000000, "other_assets": 230000000, "total_assets": 59513000000, "accounts_payable": 4276000000, "accrued_salaries": 2304000000, "other_accrued_expenses": 3899000000, "short_term_borrowings_and_long_term_debt_due_within_one_year": 4698000000, "total_current_liabilities": 15177000000, "long_term_debt": 38333000000, "professional_liability_risks": 1544000000, "right_of_use_operating_lease_obligations": 1863000000, "income_taxes_and_other_liabilities": 2041000000, "accumulated_other_comprehensive_loss": -387000000, "retained_deficit": -2115000000, "stockholders_deficit_attributable_to_hca_healthcare": -2499000000, "noncontrolling_interests": 3054000000, "total_equity": 555000000, "total_debt": 43031000000, "shares_outstanding": 249981400, "total_liabilities": 58958000000 }, "cash_flow": { "operating_cash_flow": 10514000000, "depreciation_and_amortization": 3312000000, "share_based_compensation": 360000000, "capital_expenditures": 4875000000, "acquisitions_of_hospitals_and_health_care_entities": 266000000, "sales_of_hospitals_and_health_care_entities": 328000000, "net_cash_from_investing_activities": -4933000000, "issuances_of_long_term_debt": 7495000000, "net_change_in_short_term_borrowings_and_revolving_credit_facilities": -1880000000, "repayment_of_long_term_debt": 2410000000, "distributions_to_noncontrolling_interests": 711000000, "payment_of_dividends": 690000000, "repurchase_of_common_stock": 6042000000, "net_cash_from_financing_activities": -4582000000, "change_in_cash_and_cash_equivalents": 998000000, "interest_payments": 1938000000, "income_tax_payments_net": 1844000000, "free_cash_flow": 5639000000 }, "shareholder_returns": { "cash_dividends_declared": 688000000, "cash_dividends_declared_per_share": 2.64, "shares_repurchased": 17798000, "repurchase_of_common_stock_equity_statement": 6064000000 } }, { "fiscal_year": 2023, "label": "FY2023", "period_start": "2023-01-01", "period_end": "2023-12-31", "period_type": "fiscal year", "source_accession": "0001193125-26-044769", "income_statement": { "revenues": 64968000000, "salaries_and_benefits": 29487000000, "supplies": 9902000000, "other_operating_expenses": 12875000000, "equity_in_earnings_of_affiliates": -22000000, "depreciation_and_amortization": 3077000000, "interest_expense": 1938000000, "losses_gains_on_sales_of_facilities": 5000000, "total_costs_and_expenses": 57262000000, "income_before_income_taxes": 7706000000, "provision_for_income_taxes": 1615000000, "net_income": 6091000000, "net_income_attributable_to_noncontrolling_interests": 849000000, "net_income_attributable_to_hca_healthcare": 5242000000, "basic_eps": 19.25, "diluted_eps": 18.97, "basic_shares": 272404000, "diluted_shares": 276412000 }, "cash_flow": { "operating_cash_flow": 9431000000, "depreciation_and_amortization": 3077000000, "share_based_compensation": 262000000, "capital_expenditures": 4744000000, "acquisitions_of_hospitals_and_health_care_entities": 635000000, "sales_of_hospitals_and_health_care_entities": 193000000, "net_cash_from_investing_activities": -5317000000, "issuances_of_long_term_debt": 3224000000, "net_change_in_short_term_borrowings_and_revolving_credit_facilities": -1020000000, "repayment_of_long_term_debt": 909000000, "distributions_to_noncontrolling_interests": 640000000, "payment_of_dividends": 661000000, "repurchase_of_common_stock": 3811000000, "net_cash_from_financing_activities": -4094000000, "change_in_cash_and_cash_equivalents": 27000000, "interest_payments": 1892000000, "income_tax_payments_net": 1386000000, "free_cash_flow": 4687000000 }, "shareholder_returns": { "cash_dividends_declared": 658000000, "cash_dividends_declared_per_share": 2.4, "shares_repurchased": 14465000, "repurchase_of_common_stock_equity_statement": 3842000000 } } ], "quarterly": [ { "fiscal_year": 2026, "fiscal_quarter": 3, "label": "Q3 FY2026", "period_start": "2026-07-01", "period_end": "2026-09-30", "period_type": "three months", "source_accession": "0001193125-26-437871", "cash_flow_source_accession": "0001193125-26-432665", "non_gaap_source_accession": "0001193125-26-432665", "operating_statistics_source_accession": "0001193125-26-432665", "income_statement": { "revenues": 19849000000, "salaries_and_benefits": 8581000000, "supplies": 2822000000, "other_operating_expenses": 4548000000, "equity_in_earnings_of_affiliates": -20000000, "depreciation_and_amortization": 954000000, "interest_expense": 607000000, "losses_gains_on_sales_of_facilities": -13000000, "total_costs_and_expenses": 17479000000, "income_before_income_taxes": 2370000000, "provision_for_income_taxes": 521000000, "net_income": 1849000000, "net_income_attributable_to_noncontrolling_interests": 270000000, "net_income_attributable_to_hca_healthcare": 1579000000, "basic_eps": 7.36, "diluted_eps": 7.27, "basic_shares": 214592000, "diluted_shares": 217212000 }, "balance_sheet": { "cash_and_cash_equivalents": 908000000, "accounts_receivable": 11509000000, "inventories": 1670000000, "other_current_assets": 2132000000, "total_current_assets": 16219000000, "property_and_equipment_at_cost": 69632000000, "accumulated_depreciation": -37364000000, "property_and_equipment_net": 32268000000, "investments_of_insurance_subsidiaries": 463000000, "investments_in_and_advances_to_affiliates": 815000000, "goodwill_and_other_intangible_assets": 11199000000, "right_of_use_operating_lease_assets": 2208000000, "other_assets": 280000000, "total_assets": 63452000000, "accounts_payable": 5103000000, "accrued_salaries": 2373000000, "other_accrued_expenses": 4210000000, "short_term_borrowings_and_long_term_debt_due_within_one_year": 8093000000, "total_current_liabilities": 19779000000, "long_term_debt": 42400000000, "professional_liability_risks": 1538000000, "right_of_use_operating_lease_obligations": 1933000000, "income_taxes_and_other_liabilities": 2401000000, "accumulated_other_comprehensive_loss": -350000000, "retained_deficit": -7729000000, "stockholders_deficit_attributable_to_hca_healthcare": -8077000000, "noncontrolling_interests": 3478000000, "total_equity": -4599000000, "total_debt": 50493000000, "shares_outstanding": 210880500, "total_liabilities": 68051000000 }, "shareholder_returns": { "cash_dividends_declared": 168000000, "cash_dividends_declared_per_share": 0.78, "shares_repurchased": 7230000, "repurchase_of_common_stock_equity_statement": 2999000000 }, "cash_flow": { "operating_cash_flow": 4461000000, "capital_expenditures": 1357000000, "free_cash_flow": 3104000000 }, "non_gaap": { "adjusted_ebitda": 3918000000, "adjusted_ebitda_margin_pct": 19.7, "net_income_attributable_to_hca_healthcare_as_adjusted": 1569000000, "diluted_eps_as_adjusted": 7.22 }, "operating_statistics": { "number_of_hospitals": 189, "admissions": 592179, "equivalent_admissions": 1068119, "revenue_per_equivalent_admission": 18583, "emergency_room_visits": 2607642, "inpatient_surgery_cases": 136795, "outpatient_surgery_cases": 242819, "same_facility_admissions_growth_pct": 2.7, "same_facility_equivalent_admissions_growth_pct": 3, "same_facility_revenue_per_equivalent_admission_growth_pct": 0.6, "same_facility_emergency_room_visits_growth_pct": 5.1 } }, { "fiscal_year": 2025, "fiscal_quarter": 3, "label": "Q3 FY2025", "period_start": "2025-07-01", "period_end": "2025-09-30", "period_type": "three months", "source_accession": "0001193125-26-437871", "cash_flow_source_accession": "0001193125-25-249345", "non_gaap_source_accession": "0001193125-26-432665", "operating_statistics_source_accession": "0001193125-26-432665", "income_statement": { "revenues": 19161000000, "salaries_and_benefits": 8364000000, "supplies": 2782000000, "other_operating_expenses": 4161000000, "equity_in_earnings_of_affiliates": -16000000, "depreciation_and_amortization": 889000000, "interest_expense": 561000000, "losses_gains_on_sales_of_facilities": 2000000, "total_costs_and_expenses": 16743000000, "income_before_income_taxes": 2418000000, "provision_for_income_taxes": 515000000, "net_income": 1903000000, "net_income_attributable_to_noncontrolling_interests": 260000000, "net_income_attributable_to_hca_healthcare": 1643000000, "basic_eps": 7.05, "diluted_eps": 6.96, "basic_shares": 232891000, "diluted_shares": 236181000 }, "shareholder_returns": { "cash_dividends_declared": 169000000, "cash_dividends_declared_per_share": 0.72, "shares_repurchased": 6514000, "repurchase_of_common_stock_equity_statement": 2522000000 }, "cash_flow": { "operating_cash_flow": 4416000000, "capital_expenditures": 1288000000, "free_cash_flow": 3128000000 }, "non_gaap": { "adjusted_ebitda": 3870000000, "adjusted_ebitda_margin_pct": 20.2, "net_income_attributable_to_hca_healthcare_as_adjusted": 1644000000, "diluted_eps_as_adjusted": 6.96 }, "operating_statistics": { "number_of_hospitals": 191, "admissions": 577804, "equivalent_admissions": 1038799, "revenue_per_equivalent_admission": 18446, "emergency_room_visits": 2477474, "inpatient_surgery_cases": 138563, "outpatient_surgery_cases": 253426 } } ], "year_to_date": { "fiscal_year": 2026, "label": "Nine months ended September 30, 2026", "period_start": "2026-01-01", "period_end": "2026-09-30", "period_type": "nine months", "source_accession": "0001193125-26-437871", "non_gaap_source_accession": "0001193125-26-432665", "operating_statistics_source_accession": "0001193125-26-432665", "prior_year_comparative": { "fiscal_year": 2025, "label": "Nine months ended September 30, 2025", "period_start": "2025-01-01", "period_end": "2025-09-30", "period_type": "nine months", "source_accession": "0001193125-26-437871", "non_gaap_source_accession": "0001193125-26-432665", "operating_statistics_source_accession": "0001193125-26-432665", "income_statement": { "revenues": 56087000000, "salaries_and_benefits": 24499000000, "supplies": 8390000000, "other_operating_expenses": 11799000000, "equity_in_earnings_of_affiliates": -53000000, "depreciation_and_amortization": 2612000000, "interest_expense": 1676000000, "losses_gains_on_sales_of_facilities": 4000000, "total_costs_and_expenses": 48927000000, "income_before_income_taxes": 7160000000, "provision_for_income_taxes": 1541000000, "net_income": 5619000000, "net_income_attributable_to_noncontrolling_interests": 713000000, "net_income_attributable_to_hca_healthcare": 4906000000, "basic_eps": 20.47, "diluted_eps": 20.23, "basic_shares": 239615000, "diluted_shares": 242459000 }, "cash_flow": { "operating_cash_flow": 10277000000, "depreciation_and_amortization": 2612000000, "share_based_compensation": 301000000, "capital_expenditures": 3455000000, "acquisitions_of_hospitals_and_health_care_entities": 361000000, "sales_of_hospitals_and_health_care_entities": 177000000, "net_cash_from_investing_activities": -3671000000, "issuances_of_long_term_debt": 5233000000, "net_change_in_short_term_borrowings_and_revolving_credit_facilities": 1906000000, "repayment_of_long_term_debt": 5834000000, "distributions_to_noncontrolling_interests": 631000000, "payment_of_dividends": 517000000, "repurchase_of_common_stock": 7509000000, "net_cash_from_financing_activities": -7551000000, "change_in_cash_and_cash_equivalents": -936000000, "interest_payments": 1696000000, "income_tax_payments_net": 227000000, "free_cash_flow": 6822000000 }, "non_gaap": { "adjusted_ebitda": 11452000000, "adjusted_ebitda_margin_pct": 20.4, "net_income_attributable_to_hca_healthcare_as_adjusted": 4909000000, "diluted_eps_as_adjusted": 20.24 }, "operating_statistics": { "number_of_hospitals": 191, "admissions": 1720226, "equivalent_admissions": 3068883, "revenue_per_equivalent_admission": 18276, "emergency_room_visits": 7435953, "inpatient_surgery_cases": 408444, "outpatient_surgery_cases": 758411 } }, "income_statement": { "revenues": 59188000000, "salaries_and_benefits": 25154000000, "supplies": 8561000000, "other_operating_expenses": 13771000000, "equity_in_earnings_of_affiliates": -45000000, "depreciation_and_amortization": 2828000000, "interest_expense": 1790000000, "losses_gains_on_sales_of_facilities": -22000000, "total_costs_and_expenses": 52037000000, "income_before_income_taxes": 7151000000, "provision_for_income_taxes": 1515000000, "net_income": 5636000000, "net_income_attributable_to_noncontrolling_interests": 738000000, "net_income_attributable_to_hca_healthcare": 4898000000, "basic_eps": 22.31, "diluted_eps": 22.05, "basic_shares": 219540000, "diluted_shares": 222197000 }, "cash_flow": { "operating_cash_flow": 8810000000, "depreciation_and_amortization": 2828000000, "share_based_compensation": 304000000, "capital_expenditures": 3707000000, "acquisitions_of_hospitals_and_health_care_entities": 942000000, "sales_of_hospitals_and_health_care_entities": 107000000, "net_cash_from_investing_activities": -4755000000, "issuances_of_long_term_debt": 2994000000, "net_change_in_short_term_borrowings_and_revolving_credit_facilities": 3507000000, "repayment_of_long_term_debt": 2713000000, "distributions_to_noncontrolling_interests": 574000000, "payment_of_dividends": 519000000, "repurchase_of_common_stock": 6605000000, "net_cash_from_financing_activities": -4183000000, "change_in_cash_and_cash_equivalents": -132000000, "interest_payments": 1725000000, "income_tax_payments_net": 1417000000, "free_cash_flow": 5103000000 }, "non_gaap": { "adjusted_ebitda": 11747000000, "adjusted_ebitda_margin_pct": 19.8, "net_income_attributable_to_hca_healthcare_as_adjusted": 4881000000, "diluted_eps_as_adjusted": 21.97 }, "operating_statistics": { "number_of_hospitals": 189, "admissions": 1751999, "equivalent_admissions": 3136078, "revenue_per_equivalent_admission": 18873, "emergency_room_visits": 7642872, "inpatient_surgery_cases": 403098, "outpatient_surgery_cases": 729827, "same_facility_admissions_growth_pct": 2, "same_facility_equivalent_admissions_growth_pct": 2.3, "same_facility_revenue_per_equivalent_admission_growth_pct": 3.4, "same_facility_emergency_room_visits_growth_pct": 3 } }, "trailing_twelve_months": { "label": "Twelve months ended September 30, 2026", "period_start": "2025-10-01", "period_end": "2026-09-30", "period_type": "trailing twelve months", "source_accession": "0001193125-26-437871", "derived_from_accessions": [ "0001193125-26-044769", "0001193125-26-437871" ], "income_statement": { "revenues": 78701000000, "salaries_and_benefits": 33514000000, "supplies": 11538000000, "other_operating_expenses": 17858000000, "equity_in_earnings_of_affiliates": -70000000, "depreciation_and_amortization": 3739000000, "interest_expense": 2362000000, "losses_gains_on_sales_of_facilities": -63000000, "total_costs_and_expenses": 68878000000, "income_before_income_taxes": 9823000000, "provision_for_income_taxes": 2024000000, "net_income": 7799000000, "net_income_attributable_to_noncontrolling_interests": 1023000000, "net_income_attributable_to_hca_healthcare": 6776000000 }, "cash_flow": { "operating_cash_flow": 11169000000, "capital_expenditures": 5196000000, "acquisitions_of_hospitals_and_health_care_entities": 978000000, "payment_of_dividends": 681000000, "repurchase_of_common_stock": 9163000000, "distributions_to_noncontrolling_interests": 770000000, "free_cash_flow": 5973000000 } }, "notes": [ "Annual figures come from HCA Healthcare's FY2025 Form 10-K (accession 0001193125-26-044769): income statements and cash flow statements for 2025, 2024 and 2023, and balance sheets at December 31, 2025 and 2024. FY2023 therefore carries no balance sheet, because this 10-K does not print one for that date.", "Third-quarter, nine-month and September 30, 2026 balance-sheet figures come from the Q3 2026 Form 10-Q (accession 0001193125-26-437871), which presents the quarters and nine months ended September 30, 2026 and 2025. Its December 31, 2025 balance-sheet column matches the 10-K line for line.", "The 10-Q's cash flow statement covers only the nine-month periods. The three-month operating cash flow and capital expenditures are therefore taken from the earnings releases. For Q3 FY2026, operating cash flow of $4.461 billion and capital expenditures of $1.357 billion are stated in the Q3 2026 earnings release furnished as Exhibit 99.1 to the 8-K filed October 27, 2026 (accession 0001193125-26-432665). For Q3 FY2025, operating cash flow of $4.416 billion and capital expenditures of $1.288 billion are stated in the Q3 2025 earnings release (accession 0001193125-25-249345). Each figure also equals the nine-month amount less the six-month amount the second-quarter release of the same year prints: 8,810 less 4,349 and 3,707 less 2,350 for 2026 (accession 0001193125-26-315151), and 10,277 less 5,861 and 3,455 less 2,167 for 2025 (accession 0000950170-25-098578), in millions.", "HCA does not print a gross profit or operating income line. Its costs and expenses include interest expense, so income before income taxes is the first profit subtotal. The 10-Q notes that most of its expenses are costs of revenues; corporate office costs, which could be classified as general and administrative, were $146 million in Q3 FY2026 against $139 million a year earlier.", "Revenues rose 3.6% in Q3 FY2026 to $19,849 million from $19,161 million, while net income attributable to HCA Healthcare, Inc. fell to $1,579 million from $1,643 million. Diluted EPS still rose, to $7.27 from $6.96, because diluted weighted shares fell to 217.212 million from 236.181 million. Other operating expenses rose to $4,548 million from $4,161 million. The earnings release estimates that a shift in payer mix toward uninsured patients, primarily patients who lost coverage on the health insurance exchanges, reduced the quarter's income before income taxes by approximately $400 million.", "Non-GAAP measures (Adjusted EBITDA, Adjusted EBITDA margin, and net income and diluted EPS as adjusted) and the operating statistics are as HCA reports them in the Q3 2026 earnings release (accession 0001193125-26-432665), which prints both the 2026 and 2025 columns. Adjusted EBITDA was $3,918 million in Q3 FY2026 against $3,870 million a year earlier.", "HCA reports a stockholders' deficit. Total equity, including noncontrolling interests, was a deficit of $4,599 million at September 30, 2026, against a deficit of $2,771 million at December 31, 2025 and positive equity of $555 million at December 31, 2024. The deficit attributable to HCA Healthcare, Inc. alone was $8,077 million at September 30, 2026. The statements of stockholders' equity charge most of each period's share repurchases to the retained deficit (for 2025, $9,692 million of $10,110 million).", "Total debt is the debt note's 'Total debt' line: $50,493 million at September 30, 2026, $46,492 million at December 31, 2025 and $43,031 million at December 31, 2024. At September 30, 2026 it included $5,727 million of commercial paper, against $2,207 million at December 31, 2025.", "Share repurchases: the statement of stockholders' equity (deficit) records 7.230 million shares repurchased in Q3 FY2026 for $2,999 million. The 10-Q's Part II reports 7,229,310 shares bought in the quarter at an average price of $410.85, and the earnings release states a cost of $2.970 billion. The filing does not itemize the difference between the two amounts. For the nine months, the 10-Q reports 15.139 million shares repurchased at an average price of $430.01.", "Nine-month operating cash flow was $8,810 million in 2026 against $10,277 million in 2025. The cash flow statement shows net income tax payments of $1,417 million in the 2026 nine months against $227 million in the 2025 nine months, and a $635 million increase in accounts receivable against a $345 million decrease a year earlier.", "Common shares outstanding were 210,880,500 at September 30, 2026, 224,605,100 at December 31, 2025 and 249,981,400 at December 31, 2024. The 10-Q cover reports 208,892,500 shares outstanding at October 26, 2026.", "Dividends declared per share come from the statements of stockholders' equity (deficit): $0.78 for Q3 FY2026, $0.72 for Q3 FY2025, and $2.88, $2.64 and $2.40 for 2025, 2024 and 2023.", "The trailing twelve months to September 30, 2026 are computed here as FY2025 plus the nine months ended September 30, 2026 less the nine months ended September 30, 2025. No EPS is computed for that period, because EPS is not additive across periods." ], "uncertainties": [ "The three-month cash flow figures for Q3 FY2026 and Q3 FY2025 come from the earnings releases rather than a filed cash flow statement, because the 10-Q's cash flow statement covers only nine months. Each agrees with the difference between the nine-month and six-month statements the releases print, but no three-month cash flow statement exists to confirm them against.", "The Q3 FY2025 quarter carries no balance sheet, because the Q3 2026 10-Q compares the September 30, 2026 balance sheet with December 31, 2025, not with September 30, 2025.", "The Q3 FY2026 share repurchase amount differs between the statement of stockholders' equity ($2,999 million) and the average-price disclosure and earnings release (about $2.970 billion). Both are recorded as printed; the filing does not explain the $29 million gap." ], "headline": { "period": "Q3 FY2026", "period_end_words": "September 30, 2026", "metrics": [ { "label": "Revenue", "format": "usd", "value": 19849000000, "text": "$19.85 billion", "exact": "$19,849,000,000", "compact": "$19.85B", "abs": "$19.85 billion", "prior_value": 19161000000, "prior": "$19.16 billion", "priorabs": "$19.16 billion", "yoy": "up 3.6%", "source": { "array": "quarterly", "field": "income_statement.revenues", "index": 0, "period_label": "Q3 FY2026", "period_end": "2026-09-30", "period_start": "2026-07-01", "span_days": 91, "source_accession": "0001193125-26-437871", "prior_index": 1, "prior_period_label": "Q3 FY2025", "prior_period_end": "2025-09-30", "prior_period_start": "2025-07-01", "prior_span_days": 91, "prior_source_accession": "0001193125-26-437871", "gap_days": 365 } }, { "label": "Net income", "format": "usd", "value": 1579000000, "text": "$1.58 billion", "exact": "$1,579,000,000", "compact": "$1.58B", "abs": "$1.58 billion", "prior_value": 1643000000, "prior": "$1.64 billion", "priorabs": "$1.64 billion", "yoy": "down 3.9%", "source": { "array": "quarterly", "field": "income_statement.net_income_attributable_to_hca_healthcare", "index": 0, "period_label": "Q3 FY2026", "period_end": "2026-09-30", "period_start": "2026-07-01", "span_days": 91, "source_accession": "0001193125-26-437871", "prior_index": 1, "prior_period_label": "Q3 FY2025", "prior_period_end": "2025-09-30", "prior_period_start": "2025-07-01", "prior_span_days": 91, "prior_source_accession": "0001193125-26-437871", "gap_days": 365 } }, { "label": "Diluted EPS", "format": "eps", "value": 7.27, "text": "$7.27", "exact": "$7.27", "compact": "$7.27", "abs": "$7.27", "prior_value": 6.96, "prior": "$6.96", "priorabs": "$6.96", "yoy": "up 4.5%", "source": { "array": "quarterly", "field": "income_statement.diluted_eps", "index": 0, "period_label": "Q3 FY2026", "period_end": "2026-09-30", "period_start": "2026-07-01", "span_days": 91, "source_accession": "0001193125-26-437871", "prior_index": 1, "prior_period_label": "Q3 FY2025", "prior_period_end": "2025-09-30", "prior_period_start": "2025-07-01", "prior_span_days": 91, "prior_source_accession": "0001193125-26-437871", "gap_days": 365 } }, { "label": "Equivalent admissions", "format": "plain", "value": 1068119, "text": "1,068,119", "exact": "1,068,119", "compact": "1,068,119", "abs": "1,068,119", "prior_value": 1038799, "prior": "1,038,799", "priorabs": "1,038,799", "yoy": "up 2.8%", "source": { "array": "quarterly", "field": "operating_statistics.equivalent_admissions", "index": 0, "period_label": "Q3 FY2026", "period_end": "2026-09-30", "period_start": "2026-07-01", "span_days": 91, "source_accession": "0001193125-26-432665", "prior_index": 1, "prior_period_label": "Q3 FY2025", "prior_period_end": "2025-09-30", "prior_period_start": "2025-07-01", "prior_span_days": 91, "prior_source_accession": "0001193125-26-432665", "gap_days": 365 } }, { "label": "Adjusted EBITDA margin", "format": "pct", "value": 19.7, "text": "19.7%", "exact": "19.7%", "compact": "19.7%", "abs": "19.7%", "prior_value": 20.2, "prior": "20.2%", "priorabs": "20.2%", "yoy": "down 0.5 points", "source": { "array": "quarterly", "field": "non_gaap.adjusted_ebitda_margin_pct", "index": 0, "period_label": "Q3 FY2026", "period_end": "2026-09-30", "period_start": "2026-07-01", "span_days": 91, "source_accession": "0001193125-26-432665", "prior_index": 1, "prior_period_label": "Q3 FY2025", "prior_period_end": "2025-09-30", "prior_period_start": "2025-07-01", "prior_span_days": 91, "prior_source_accession": "0001193125-26-432665", "gap_days": 365 } } ], "summary": "HCA Healthcare reported $19.85 billion in revenue for Q3 FY2026, the quarter ended September 30, 2026, up 3.6% from a year earlier, while net income attributable to HCA Healthcare was $1.58 billion, down 3.9%. Diluted earnings per share were $7.27, up 4.5%, because share repurchases reduced the diluted share count. Patient volume grew, with equivalent admissions up 2.8%, but HCA Healthcare said a shift toward uninsured patients, mainly people who lost coverage on the health insurance exchanges, reduced its pretax income, and its adjusted EBITDA margin was 19.7%, down 0.5 points from 20.2%.", "qa": [ { "q": "How much revenue did HCA Healthcare make in Q3 FY2026?", "a": "HCA Healthcare reported $19.85 billion in revenue for Q3 FY2026, the quarter ended September 30, 2026, up 3.6% from $19.16 billion a year earlier. Equivalent admissions, a volume measure that adjusts inpatient admissions for outpatient activity, were 1,068,119, up 2.8%." }, { "q": "What was HCA Healthcare's net income in Q3 FY2026?", "a": "Net income attributable to HCA Healthcare was $1.58 billion for Q3 FY2026, the quarter ended September 30, 2026, down 3.9% from $1.64 billion a year earlier. HCA Healthcare said a shift toward uninsured patients, mainly people who lost coverage on the health insurance exchanges, reduced its pretax income in the quarter." }, { "q": "What was HCA Healthcare's EPS in Q3 FY2026?", "a": "HCA Healthcare earned $7.27 per diluted share in Q3 FY2026, up 4.5% from $6.96 a year earlier. Earnings per share grew even though net income attributable to HCA Healthcare declined, because share repurchases reduced the diluted share count." }, { "q": "Why did HCA Healthcare's margin shrink in Q3 FY2026?", "a": "HCA Healthcare's adjusted EBITDA margin, a non-GAAP measure, was 19.7% in Q3 FY2026, down 0.5 points from 20.2% a year earlier. HCA Healthcare said a shift toward uninsured patients, mainly people who lost coverage on the health insurance exchanges, reduced its pretax income in the quarter, and other operating expenses rose as a share of revenues." } ] }, "company_details": { "Name": "HCA Healthcare, Inc.", "Ticker": "HCA", "CIK": "0000860730", "Exchange": "NYSE", "State": "Tennessee", "Incorporation": "", "SIC": "8062", "Office": "Industrial Applications and Services", "Industry": "Services-General Medical & Surgical Hospitals, NEC" }, "next_filing": { "predicted_date": "2027-02-09", "predicted_type": "10-K" }, "fiscal_period": { "fiscal_year": 2026, "fiscal_period": "Q3", "tag": "FY26Q3", "period_end": "2026-09-30", "form": "10-Q", "accession": "0001193125-26-437871", "fiscal_year_end": "1231", "source": "facts" }, "source_filings": [ { "role": "annual", "current": false, "form": "10-K", "fiscal_year": 2025, "fiscal_period": "FY", "tag": "FY25", "period_end": "2025-12-31", "filed": "2026-02-10", "accession": "0001193125-26-044769", "url": "https://www.sec.gov/Archives/edgar/data/860730/000119312526044769/hca-20251231.htm", "source": "reported" }, { "role": "quarterly", "current": true, "form": "10-Q", "fiscal_year": 2026, "fiscal_period": "Q3", "tag": "FY26Q3", "period_end": "2026-09-30", "filed": "2026-10-29", "accession": "0001193125-26-437871", "url": "https://www.sec.gov/Archives/edgar/data/860730/000119312526437871/hca-20260930.htm", "source": "facts" } ], "figure_sources": { "about": "Where each figure in this file is printed in its SEC filing. This block mirrors the paths of the figures: figure_sources.annual[0].income_statement.net_income is the source of annual[0].income_statement.net_income. Each entry reads '#', and the link is documents[] + '#': it opens the filing at the line that prints that number. A figure with no entry is not printed in a tagged filing, either because it was calculated (margins, free cash flow, trailing twelve months, a quarter derived by subtraction) or because it comes from an untagged earnings release.", "documents": { "d1": "https://www.sec.gov/Archives/edgar/data/860730/000119312526044769/hca-20251231.htm", "d2": "https://www.sec.gov/Archives/edgar/data/860730/000119312526437871/hca-20260930.htm" }, "annual": [ { "period_end": "2025-12-31", "income_statement": { "revenues": "d1#F_313df335-eef7-431c-959d-de92a5620120", "salaries_and_benefits": "d1#F_56026514-1504-4995-b17a-b0526620cb80", "supplies": "d1#F_c61d3ec6-7c5a-4e16-88f2-4bc35df6b05c", "other_operating_expenses": "d1#F_6d636105-aadc-46c9-8a9c-acb155e04e5b", "equity_in_earnings_of_affiliates": "d1#F_a313fa54-083d-4c23-892b-d64757c0082c", "depreciation_and_amortization": "d1#F_b37ff4d0-aa60-4f27-85e7-43d06e9624a6", "interest_expense": "d1#F_db8fdcc3-648b-4362-bf8e-3ff9d2e08369", "losses_gains_on_sales_of_facilities": "d1#F_f0e52113-c4a6-4faa-b77a-f094aaf4003e", "total_costs_and_expenses": "d1#F_bf2d48f5-0208-409f-ab0c-bc7ca5afc23d", "income_before_income_taxes": "d1#F_6f886aa8-3097-4605-8e8e-2fadf20bce1e", "provision_for_income_taxes": "d1#F_33984075-e1e2-45f2-9ffc-7efa841e60a5", "net_income": "d1#F_55a5fccb-e3f2-4379-96c6-0b27d8ae1732", "net_income_attributable_to_noncontrolling_interests": "d1#F_d3f8b426-0b1c-417b-9b51-18da0f267876", "net_income_attributable_to_hca_healthcare": "d1#F_d34d45d0-98c7-4237-8864-13ee4c40684e", "basic_eps": "d1#F_764236cd-1623-4175-a0ce-0735f5724aab", "diluted_eps": "d1#F_a4a29561-c7e7-4d0b-8e08-21998ae0df9c", "basic_shares": "d1#F_fa0b890f-7f4a-461d-8e74-8c6e36be9c6e", "diluted_shares": "d1#F_8d9cb6eb-d3bc-4d30-b463-dac1c8214ee6" }, "balance_sheet": { "cash_and_cash_equivalents": "d1#F_09f27352-5592-4be3-b876-a7f06186898b", "accounts_receivable": "d1#F_865c7ae2-4d67-4043-89b8-1ed19cf7b54f", "inventories": "d1#F_92e062c0-0e43-4302-854c-fdf08c0e8fdd", "other_current_assets": "d1#F_2397beab-f9a4-4c98-af94-d719ab6efa94", "total_current_assets": "d1#F_740e649c-4dad-4971-8be3-3abbbc3c90c5", "property_and_equipment_at_cost": "d1#F_496e4aae-63a4-494d-ba80-34a02a6a8791", "accumulated_depreciation": "d1#F_c2700c7a-e989-43d2-be60-e2ee49093e83", "property_and_equipment_net": "d1#F_01dae7ce-bed7-4864-bf2f-8b3ab2b783ae", "investments_of_insurance_subsidiaries": "d1#F_337d2ee1-58b3-40c2-8190-97fe532b8f93", "investments_in_and_advances_to_affiliates": "d1#F_45ba04f2-b405-4ce8-a1cc-c85bc71a280c", "goodwill_and_other_intangible_assets": "d1#F_c60cb799-be53-411d-a6be-ee3a5d51c3f1", "right_of_use_operating_lease_assets": "d1#F_951c4bdd-edb5-4e59-88b8-480e80ed790d", "other_assets": "d1#F_e98ea2d5-5942-4454-9255-ccddbf921fc9", "total_assets": "d1#F_5156e7ad-4b4b-4d7b-8b75-b39b62485ca2", "accounts_payable": "d1#F_22059b03-93a8-4403-acc7-29fb14b9629b", "accrued_salaries": "d1#F_be3b4389-3e46-423f-989c-22f8dfdbea78", "other_accrued_expenses": "d1#F_c74d38bd-e2a3-470e-aa52-c30c8ef9d4a0", "short_term_borrowings_and_long_term_debt_due_within_one_year": "d1#F_e00c83d3-7aca-4f4c-8dc2-96e1eff07a9d", "total_current_liabilities": "d1#F_d4826ea4-77df-4bcb-9b2f-aad6aae20932", "long_term_debt": "d1#F_791bd749-1350-4565-a646-4d35c93f92a3", "professional_liability_risks": "d1#F_2ba1de89-e7f0-4b48-981d-26fc3ccba9d7", "right_of_use_operating_lease_obligations": "d1#F_fe034177-5738-45cc-bd75-2f9a0d0028ac", "income_taxes_and_other_liabilities": "d1#F_58d5c827-1268-4a98-a659-d7c36b273063", "accumulated_other_comprehensive_loss": "d1#F_92da9387-f1ff-4a23-8a65-574d12109679", "retained_deficit": "d1#F_d9949de9-6d1f-4f7e-b20e-6e17c9bdb3a5", "stockholders_deficit_attributable_to_hca_healthcare": "d1#F_43399ab9-665a-4090-a445-bee70cc9197c", "noncontrolling_interests": "d1#F_1c5a412c-6a32-4e7b-bdb9-3d98ca63cf1f", "total_equity": "d1#F_ecc5537f-35b2-454a-a1fb-df768d8d3ed4", "total_debt": "d1#F_8f788a8c-bd24-4d0b-bd9a-ab90a3a5aa8c", "shares_outstanding": "d1#F_a252cabd-142e-4335-b350-7777b350dba4" }, "cash_flow": { "operating_cash_flow": "d1#F_dd028d36-3273-4ad1-89ce-7404700bfcea", "depreciation_and_amortization": "d1#F_cbe5c9e0-94bf-428b-9b4a-964f894ae8ad", "share_based_compensation": "d1#F_03090dac-15ee-44ea-be50-ef44deb19624", "capital_expenditures": "d1#F_61c0f2ff-631f-49a0-ad8c-724362822664", "acquisitions_of_hospitals_and_health_care_entities": "d1#F_d41b4eef-5f5d-4b66-a54f-269d83b73756", "sales_of_hospitals_and_health_care_entities": "d1#F_45699aa1-8117-47d9-9ba7-a7f0f8283a72", "net_cash_from_investing_activities": "d1#F_e528002e-175a-4423-82f0-b65ef62bb065", "issuances_of_long_term_debt": "d1#F_bc138f45-9174-416c-871f-36926860ee7d", "net_change_in_short_term_borrowings_and_revolving_credit_facilities": "d1#F_9e30b259-d0a2-4f98-8f2c-c24c47acafc0", "repayment_of_long_term_debt": "d1#F_ab3d5ef0-2db3-460d-901b-f812249b633f", "distributions_to_noncontrolling_interests": "d1#F_3d73c51d-8d5b-4e7f-a3c3-761ceb70494e", "payment_of_dividends": "d1#F_563c5113-7358-45a5-a5a1-46afc1807b2e", "repurchase_of_common_stock": "d1#F_cec47e4a-be1e-4897-bcc3-684c33ed4e89", "net_cash_from_financing_activities": "d1#F_d9fffc7f-5401-48ba-b67e-0916d2873852", "change_in_cash_and_cash_equivalents": "d1#F_8594e6c2-cec6-44d9-97ef-8185e773e839", "interest_payments": "d1#F_bc60538f-86b7-49b3-b4d4-003b43209836", "income_tax_payments_net": "d1#F_ff1cb1a9-92fd-47e9-a80a-e695abe7d02e" }, "shareholder_returns": { "cash_dividends_declared": "d1#F_95c4149d-86cd-4954-9b49-2f8a76d506fe", "cash_dividends_declared_per_share": "d1#F_40b0c479-145c-40fb-b3cb-75afffccb53b", "shares_repurchased": "d1#F_3bb643af-402b-48fc-a3d9-dbdf09428b73", "repurchase_of_common_stock_equity_statement": "d1#F_4cf44f29-9a90-4159-8627-5dcf511c8af5" } }, { "period_end": "2024-12-31", "income_statement": { "revenues": "d1#F_977ef44e-a2bb-468f-8269-25cdd156447b", "salaries_and_benefits": "d1#F_747da87f-2469-4639-848c-9187eeeb275e", "supplies": "d1#F_c83d7a5a-7102-439f-92e3-913366d76477", "other_operating_expenses": "d1#F_7a77dc48-365d-45ff-b586-86d43a7d2cf3", "equity_in_earnings_of_affiliates": "d1#F_c7fe3ce2-8f96-4ed1-a5f4-fcd3ddc57ce1", "depreciation_and_amortization": "d1#F_64185a44-1366-4628-b1c4-6a63d92ed6d7", "interest_expense": "d1#F_efe1fdeb-2240-495e-b78a-d3a710cdf693", "losses_gains_on_sales_of_facilities": "d1#F_5c49fb06-f2af-4590-9a2f-6ed3dfa607ac", "total_costs_and_expenses": "d1#F_5454b7ff-bd10-495d-a9e0-82a69586e238", "income_before_income_taxes": "d1#F_ccce53cf-ca52-4d94-bf3a-01d9956a34e6", "provision_for_income_taxes": "d1#F_613825b2-ad57-4288-baf2-07006a0df64c", "net_income": "d1#F_62a04186-7051-4505-82f2-717323405c0e", "net_income_attributable_to_noncontrolling_interests": "d1#F_3c30d617-de5d-4c41-a6d8-62ae5e06ed5a", "net_income_attributable_to_hca_healthcare": "d1#F_76e924e2-5c07-4a61-b2f1-ef62743ba3dc", "basic_eps": "d1#F_ec9a3288-c77f-4f3c-8539-04df14473cb3", "diluted_eps": "d1#F_dea01e3e-df5a-4f4e-8733-9b3535b2d25b", "basic_shares": "d1#F_f2ba5401-4398-4be0-994f-d3273833bd56", "diluted_shares": "d1#F_151c1ea3-8e5b-42a6-9b8d-edcd292bc61f" }, "balance_sheet": { "cash_and_cash_equivalents": "d1#F_e3a407b2-264a-4d61-b782-815f08b2f5d6", "accounts_receivable": "d1#F_12f4997e-4a0c-4ada-84fb-98ff8173b75d", "inventories": "d1#F_c8565d04-a260-4980-9203-2f80fb866169", "other_current_assets": "d1#F_482965b3-bc08-4eb4-ade3-630bc8b15d6a", "total_current_assets": "d1#F_3b47af07-c7c5-4038-aa9f-f8f24fcfa5c8", "property_and_equipment_at_cost": "d1#F_cc278b7c-cc2c-4032-aef7-8098bbdf169c", "accumulated_depreciation": "d1#F_1b98ff6a-9b98-4615-836d-c96bccf18a4a", "property_and_equipment_net": "d1#F_83b01f12-ae20-45ac-be8d-137ae6f79efc", "investments_of_insurance_subsidiaries": "d1#F_9b859aa4-cf9b-404d-9e93-062a8e7100ef", "investments_in_and_advances_to_affiliates": "d1#F_47dbcc62-fc64-4f0a-9136-48e3e22c2002", "goodwill_and_other_intangible_assets": "d1#F_8f2f9ead-d9a4-48c2-b28a-7e628b25cd7f", "right_of_use_operating_lease_assets": "d1#F_83d19f13-f08e-497c-ac3c-1af67f05414e", "other_assets": "d1#F_12f0bdf3-83fa-4cb6-9415-28f1ba040a77", "total_assets": "d1#F_5a1b655f-ab49-4156-a5e7-cb32eff7628a", "accounts_payable": "d1#F_ed1d54da-8954-4709-915d-f09e603e46ae", "accrued_salaries": "d1#F_c4dcabb9-0cfe-4c01-95bc-89f36ea2ce18", "other_accrued_expenses": "d1#F_a16dbad0-e27d-4b6f-9bb3-81e864648170", "short_term_borrowings_and_long_term_debt_due_within_one_year": "d1#F_0baaa8bd-d9dd-4a6c-81dd-b4b82a432fca", "total_current_liabilities": "d1#F_797ba739-5b7b-42dc-bc7d-389a12be5647", "long_term_debt": "d1#F_a9fee7a6-911d-42b7-b7b8-f3a6c6efdbe8", "professional_liability_risks": "d1#F_8f61b569-5bed-482a-a6eb-c135f5003e5e", "right_of_use_operating_lease_obligations": "d1#F_dbdca874-439a-4878-9098-8fbf6f49d97b", "income_taxes_and_other_liabilities": "d1#F_2496e4de-ddd4-4f0d-bb5d-d452f2ba5226", "accumulated_other_comprehensive_loss": "d1#F_d391427c-74a4-442a-8e90-2774279a133c", "retained_deficit": "d1#F_f9e38964-aa2d-43c1-9b66-4673ddf5e0ae", "stockholders_deficit_attributable_to_hca_healthcare": "d1#F_fe6cb9ee-fede-42c6-ac2e-00df33cd1e2b", "noncontrolling_interests": "d1#F_d68e7c96-0ee8-463b-a9ee-7aece209b8d0", "total_equity": "d1#F_59f64010-a991-4b88-bb12-d04398f0205b", "total_debt": "d1#F_ca902dc7-0996-4ef8-ac46-b9918dc5065f", "shares_outstanding": "d1#F_0912f714-3877-4c28-9f80-372e533f905d" }, "cash_flow": { "operating_cash_flow": "d1#F_03f1ffbb-6544-4e63-9501-dfe4712722af", "depreciation_and_amortization": "d1#F_6866f88f-f6ee-4696-90bb-cfb2fd600c44", "share_based_compensation": "d1#F_01da4e30-6dd6-4786-950a-394a91e9cbb5", "capital_expenditures": "d1#F_1da092a9-8152-4a47-9830-4202a4fe01f8", "acquisitions_of_hospitals_and_health_care_entities": "d1#F_2854d2b9-8ffb-4173-9fbe-fdcfc66122f6", "sales_of_hospitals_and_health_care_entities": "d1#F_92e06a41-5867-4a64-9402-8abb96fd1a3a", "net_cash_from_investing_activities": "d1#F_18464aef-b84e-45f0-a482-c87d1bbc055a", "issuances_of_long_term_debt": "d1#F_1125d975-67c9-44cf-8f8f-e061c2d85dbb", "net_change_in_short_term_borrowings_and_revolving_credit_facilities": "d1#F_610be00b-4a99-4ca4-9b49-043f516def6c", "repayment_of_long_term_debt": "d1#F_e9d30739-fe0a-4762-9f2a-521fa4edad40", "distributions_to_noncontrolling_interests": "d1#F_b9bfdd9e-04d6-451e-953f-ba1bd611b939", "payment_of_dividends": "d1#F_f909d9f4-5e91-43f8-8fe6-0a1a1abb64fe", "repurchase_of_common_stock": "d1#F_677fcfd0-c189-4d3c-8966-ffb34a1b3000", "net_cash_from_financing_activities": "d1#F_306a1a25-1e95-4331-9c75-e12e846b6a3e", "change_in_cash_and_cash_equivalents": "d1#F_c1b4e171-e668-47cc-b734-ae5e49c896a0", "interest_payments": "d1#F_f47f9f15-f351-4033-b25a-72b588df3b18", "income_tax_payments_net": "d1#F_658a21b8-a425-4db6-8258-e22b290d1781" }, "shareholder_returns": { "cash_dividends_declared": "d1#F_e3d7c8bb-550d-41b5-8b4f-33ecc2850091", "cash_dividends_declared_per_share": "d1#F_cd91a770-40c0-4728-987f-ea69c9606e8e", "shares_repurchased": "d1#F_871464f6-1a2e-4539-ac1b-06f473ebc09e", "repurchase_of_common_stock_equity_statement": "d1#F_ccd556c9-3297-4ebf-ab9c-e9639224e573" } }, { "period_end": "2023-12-31", "income_statement": { "revenues": "d1#F_66d707d3-f268-43d1-a7a5-682662f52217", "salaries_and_benefits": "d1#F_b94963f2-31cd-45e4-b34d-19e9beac3fc9", "supplies": "d1#F_f900e431-97f4-4e93-8021-54ddf467f65a", "other_operating_expenses": "d1#F_4350ff47-7ea7-4a38-976f-a15b19d6afce", "equity_in_earnings_of_affiliates": "d1#F_4bbd6046-6576-45ed-ae68-1f1f7e1eec1d", "depreciation_and_amortization": "d1#F_f09c4d17-0a8d-4555-88c7-4c7f9e116e5f", "interest_expense": "d1#F_8b32bb89-8e7e-4f95-920b-d9cd9109f2c8", "losses_gains_on_sales_of_facilities": "d1#F_b3066615-344a-479b-9e64-83a2fb386518", "total_costs_and_expenses": "d1#F_be608d0e-3e4c-42ad-b09b-dc6581b546a0", "income_before_income_taxes": "d1#F_7494b5cb-a280-4f6b-99d6-18fec263a2a7", "provision_for_income_taxes": "d1#F_73b73d6d-2ffc-4316-8bc1-20588a1f9bc1", "net_income": "d1#F_21bd88fb-3ce3-4116-811d-d5440fc9e850", "net_income_attributable_to_noncontrolling_interests": "d1#F_51ce482b-f0d5-42c0-858a-99909825f870", "net_income_attributable_to_hca_healthcare": "d1#F_6d576541-4ff3-4acc-b350-5858664c9cdf", "basic_eps": "d1#F_6e80d755-188c-45d9-ad0e-c58e07ad7141", "diluted_eps": "d1#F_f635d080-d06d-46fb-b986-8feb8234470d", "basic_shares": "d1#F_6a597900-3013-45a7-9559-2782b66b4a05", "diluted_shares": "d1#F_1f810166-e5f1-4bc2-b2c8-f37751780cd3" }, "cash_flow": { "operating_cash_flow": "d1#F_0dda754e-82eb-43e7-bc46-e2356b07a903", "depreciation_and_amortization": "d1#F_be5257d8-e480-489d-b619-3e96029f72f0", "share_based_compensation": "d1#F_ea992f8b-391f-45b5-9057-2e65c4d121cf", "capital_expenditures": "d1#F_be96c3f3-438a-4100-bb30-b5af04f3eb4e", "acquisitions_of_hospitals_and_health_care_entities": "d1#F_e0d0853f-d782-48dd-a116-26a36fdd1a26", "sales_of_hospitals_and_health_care_entities": "d1#F_65746d8e-20e1-488b-83ad-6f40be3c22e2", "net_cash_from_investing_activities": "d1#F_d72c56ef-e46c-4f49-99b5-0d60a3ed6033", "issuances_of_long_term_debt": "d1#F_1fd64c74-52f7-4574-9d99-37d92fbcce20", "net_change_in_short_term_borrowings_and_revolving_credit_facilities": "d1#F_acef79a9-78de-46a5-9629-2bcfba8a95ae", "repayment_of_long_term_debt": "d1#F_cfcd5101-282b-4f54-8c9f-87f6fabb07ce", "distributions_to_noncontrolling_interests": "d1#F_34ef0d01-d8c3-4cc3-b84f-f5565a40c57b", "payment_of_dividends": "d1#F_3bd40af4-efa1-4c70-a60d-0964ae4cc65b", "repurchase_of_common_stock": "d1#F_101474c9-901e-4a4b-b96d-3556e9ce4e5c", "net_cash_from_financing_activities": "d1#F_18b4bae3-4bdd-4d81-9092-cd002e3efe3f", "change_in_cash_and_cash_equivalents": "d1#F_6cab1e19-d6df-4664-9d5d-ec645f24abd5", "interest_payments": "d1#F_269cf357-934f-40f8-b612-c25519464ebf", "income_tax_payments_net": "d1#F_5f42ea5d-b07c-4441-9114-8578f2f655b9" }, "shareholder_returns": { "cash_dividends_declared": "d1#F_671109b5-3aea-42be-b16f-955eb9971513", "cash_dividends_declared_per_share": "d1#F_638c3571-727b-4f6f-8257-463b8b8777db", "shares_repurchased": "d1#F_dee4a93c-5a34-45d9-b529-7c2804b20499", "repurchase_of_common_stock_equity_statement": "d1#F_96adb8be-312b-4739-b13b-68032ab7cede" } } ], "quarterly": [ { "period_end": "2026-09-30", "income_statement": { "revenues": "d2#F_8307ef45-bfc4-405b-814d-45a63f72cb2c", "salaries_and_benefits": "d2#F_a2d6c7c4-a128-4c05-90b1-85c0927c3854", "supplies": "d2#F_06e52842-5673-408b-8d29-f780d354a1e2", "other_operating_expenses": "d2#F_ce6a67ee-80fb-4058-a739-e9eeff717b1a", "equity_in_earnings_of_affiliates": "d2#F_c7a522ab-d980-42ca-9ee1-14cb9b25fc34", "depreciation_and_amortization": "d2#F_7dc75c31-e740-46e1-ba55-4af701964ce8", "interest_expense": "d2#F_48a42de9-597c-4be9-b547-95cf5aefdc0c", "losses_gains_on_sales_of_facilities": "d2#F_af64cdff-b877-4778-9f19-55fb3a7fbae5", "total_costs_and_expenses": "d2#F_e4b97ef7-08fb-4afd-8f93-5445295fae02", "income_before_income_taxes": "d2#F_b3a587ec-a1da-4cde-a57a-281f091cb4b9", "provision_for_income_taxes": "d2#F_dae8c554-7323-4feb-bb03-25364ed5fb5f", "net_income": "d2#F_cdda6f62-7a68-46dc-a870-c793b4f7727b", "net_income_attributable_to_noncontrolling_interests": "d2#F_1bbd4bb5-ebe2-42c9-9882-5bac0324be62", "net_income_attributable_to_hca_healthcare": "d2#F_56e02e86-09f9-49b8-bac8-4888276a6cfb", "basic_eps": "d2#F_9cd2453c-1df9-475a-887d-2c8393ed7839", "diluted_eps": "d2#F_b4d37601-e757-4cf0-be73-435d98206758", "basic_shares": "d2#F_99da1a16-66ab-434a-9956-734e339c0488", "diluted_shares": "d2#F_a32d7dff-8602-47c9-b49e-962703fcb9f3" }, "balance_sheet": { "cash_and_cash_equivalents": "d2#F_062ce044-8631-4e5a-8223-54209bf840ab", "accounts_receivable": "d2#F_c05874e7-0e05-4add-8f34-73c062153c41", "inventories": "d2#F_592c11f4-7673-434e-ae66-8980fe1a8674", "other_current_assets": "d2#F_7753d12c-7a08-427d-bc5b-8288e025ae1f", "total_current_assets": "d2#F_ffa0f67d-3057-4d46-ba46-280e3540e1db", "property_and_equipment_at_cost": "d2#F_234a4c5b-6479-44a5-8316-2af90f0dd62b", "accumulated_depreciation": "d2#F_05801e51-867a-4225-a251-9202926a759a", "property_and_equipment_net": "d2#F_14e72bb1-db24-4fe1-869e-d43ac434c397", "investments_of_insurance_subsidiaries": "d2#F_4cdc5b32-72d4-46c4-a5b7-a983be35f4c2", "investments_in_and_advances_to_affiliates": "d2#F_cd4adf4b-8f51-4432-93a0-f87a6ba50802", "goodwill_and_other_intangible_assets": "d2#F_a65dc928-0a85-43c1-930e-3c929cfd86eb", "right_of_use_operating_lease_assets": "d2#F_80382088-7116-410d-801e-b204d82a00be", "other_assets": "d2#F_394c7f49-7f8b-4d27-b969-4a16f7808e1b", "total_assets": "d2#F_a8cd1e17-9089-4f84-a238-1068fb1db91c", "accounts_payable": "d2#F_9bf65ac0-0d80-4719-994a-e256c9727712", "accrued_salaries": "d2#F_f913de42-c3af-42c8-aa34-379bce751b53", "other_accrued_expenses": "d2#F_385a386a-02f2-48a0-a999-c278c4aaa30d", "short_term_borrowings_and_long_term_debt_due_within_one_year": "d2#F_83fe4b8c-9d3e-4d96-bf3f-951c51ccd803", "total_current_liabilities": "d2#F_6d240126-5ad5-4128-9f21-4109a1490f00", "long_term_debt": "d2#F_696f875f-37e2-4927-8c02-34d69c7868c8", "professional_liability_risks": "d2#F_24825afe-19c4-48b2-8cb7-3f82133402cb", "right_of_use_operating_lease_obligations": "d2#F_4108810c-572f-4453-8c6d-821972f2e01f", "income_taxes_and_other_liabilities": "d2#F_5b4ea581-532b-4011-9a24-230c490c748b", "accumulated_other_comprehensive_loss": "d2#F_7d87f103-f057-4ae8-afad-d43af44f3df0", "retained_deficit": "d2#F_b3ca5c78-ccb4-42d0-ba0a-6c475572781b", "stockholders_deficit_attributable_to_hca_healthcare": "d2#F_cc5f094f-b9d7-4617-84ef-64024c686c7e", "noncontrolling_interests": "d2#F_f98c4ec2-94b6-4bc6-8c0b-12246b6b77c6", "total_equity": "d2#F_bbdd69bb-5f13-43f4-9633-c6c17e58adf4", "total_debt": "d2#F_6e2f5938-f1ae-4700-8ec6-50ba81b4b47e", "shares_outstanding": "d2#F_461e331b-6f4b-4059-bcca-1c22ad813e49" }, "shareholder_returns": { "cash_dividends_declared": "d2#F_928777ea-455d-415f-84f9-e202563cd8bf", "cash_dividends_declared_per_share": "d2#F_bfc387b8-d4e6-48d1-903b-c425af4f14d8", "shares_repurchased": "d2#F_ea2d86f8-8036-46e6-838b-1a7ca5985513", "repurchase_of_common_stock_equity_statement": "d2#F_43d98257-0709-4eee-a111-018518932a57" }, "operating_statistics": { "number_of_hospitals": "d2#F_c80656d4-1a81-415b-a392-fa71bcb59602" } }, { "period_end": "2025-09-30", "income_statement": { "revenues": "d2#F_f36e8b35-ed76-48d7-a4e1-0dcd364cce42", "salaries_and_benefits": "d2#F_a929e784-1077-4214-adcb-bfa661b9b487", "supplies": "d2#F_212a4c01-7a13-4e9d-896f-d3699cf23283", "other_operating_expenses": "d2#F_d11ced10-4013-4688-8bc1-937f5d12cf32", "equity_in_earnings_of_affiliates": "d2#F_df828bb9-d734-434a-9ef0-2c8519a323af", "depreciation_and_amortization": "d2#F_7dec2970-b7e5-406b-a3c4-478a5d362bf2", "interest_expense": "d2#F_6b4f090e-5081-429d-91b7-1468777e0ca6", "losses_gains_on_sales_of_facilities": "d2#F_6b0d64bf-4bbb-4dcc-ac3f-b9f20e5fcf6c", "total_costs_and_expenses": "d2#F_35bf2cc6-366c-4e57-896e-ab4cc7221e6c", "income_before_income_taxes": "d2#F_47d3e553-f572-4589-976a-ddd733018630", "provision_for_income_taxes": "d2#F_33b9fae7-ce4b-460d-b83e-ac2b636727cd", "net_income": "d2#F_3a19ed65-978e-4455-a2f2-b5fe866bcff0", "net_income_attributable_to_noncontrolling_interests": "d2#F_79ea8e24-43fd-438a-b23d-208aa1a6bd2b", "net_income_attributable_to_hca_healthcare": "d2#F_0cacc8ab-7d1b-49c9-94fa-6b4f8d0fd89b", "basic_eps": "d2#F_606fb1b5-6a4a-4c1c-817f-20939e4189dd", "diluted_eps": "d2#F_5c199d6d-a819-4b8b-aa59-9fb2cb975f9c", "basic_shares": "d2#F_d4d89a44-899f-4242-8b49-ebb2395ff261", "diluted_shares": "d2#F_caf0d7de-5c27-4a8f-bd49-ede00bb83d0c" }, "shareholder_returns": { "cash_dividends_declared": "d2#F_ebec72b2-984e-48a1-8e4e-e61e23838c4e", "cash_dividends_declared_per_share": "d2#F_2316e9c9-175f-4d7e-a11e-7ba4fce92418", "shares_repurchased": "d2#F_dd27a0cf-7aea-4841-81a7-134f52a74886", "repurchase_of_common_stock_equity_statement": "d2#F_94ae1ec5-4b50-442b-a054-eb926fd1f0a9" }, "non_gaap": { "diluted_eps_as_adjusted": "d2#F_5c199d6d-a819-4b8b-aa59-9fb2cb975f9c" } } ], "year_to_date": { "income_statement": { "revenues": "d2#F_60d56944-dc2e-4d60-9d45-9115ee590adf", "salaries_and_benefits": "d2#F_e572c7b9-830c-49cb-8074-86750d549a33", "supplies": "d2#F_6366649f-b411-4f74-a140-e397f80b983f", "other_operating_expenses": "d2#F_33e3f7ab-17b3-4ff1-a524-23b8030d4fab", "equity_in_earnings_of_affiliates": "d2#F_99ca1457-1ad6-4ed0-8275-439cfe61929b", "depreciation_and_amortization": "d2#F_17a4daa8-45cf-4ccd-bc40-87fe43145b19", "interest_expense": "d2#F_065307cf-5f42-4d67-91bb-bed3f4a22c83", "losses_gains_on_sales_of_facilities": "d2#F_47fbf9a1-2017-43b0-b2fd-5ffc10ba35e9", "total_costs_and_expenses": "d2#F_1efe1ef1-7065-49ea-bcb9-dd241dc4ed52", "income_before_income_taxes": "d2#F_6eac1603-9249-4a45-becd-d3cbb5bd5c24", "provision_for_income_taxes": "d2#F_392e7c32-e0a4-4319-abe1-02cae11babd2", "net_income": "d2#F_bb0488a0-746b-431e-abde-a317a0a9f1fa", "net_income_attributable_to_noncontrolling_interests": "d2#F_d347940d-255a-42eb-9d5e-cf964a786e40", "net_income_attributable_to_hca_healthcare": "d2#F_773cbbfd-0f59-46e7-a89b-b23772a17974", "basic_eps": "d2#F_043c6714-4513-4101-8f1b-37e8a73c4484", "diluted_eps": "d2#F_ca3bb64f-5d9b-4a2b-a042-45bd95d51dfa", "basic_shares": "d2#F_291fa396-4edf-447e-8835-696f1444206c", "diluted_shares": "d2#F_3344808f-dedb-4962-9c77-a43aa1c295b3" }, "cash_flow": { "operating_cash_flow": "d2#F_f9a961ff-c438-4b0c-ae5f-184bb511abb1", "depreciation_and_amortization": "d2#F_b7df29bb-c3d1-4554-9c8d-d022786341ab", "share_based_compensation": "d2#F_67d05628-5f7a-4e45-8a4f-e3ec6e9fe891", "capital_expenditures": "d2#F_c4aba962-3742-4f76-ac25-42ec848107b4", "acquisitions_of_hospitals_and_health_care_entities": "d2#F_f2bf5385-bf85-408a-8c5d-5f30ffab4a33", "sales_of_hospitals_and_health_care_entities": "d2#F_4039cd48-4793-4581-9e47-b9e3ea7a0aa1", "net_cash_from_investing_activities": "d2#F_60c7ea8d-1b17-4a2c-99fd-cfe4fe13420e", "issuances_of_long_term_debt": "d2#F_028c3f0f-b35c-4545-9b5a-278abc7415fd", "net_change_in_short_term_borrowings_and_revolving_credit_facilities": "d2#F_300d8405-427d-4be6-b6c6-0d702c0178e0", "repayment_of_long_term_debt": "d2#F_b682e133-e30e-411d-b690-c349955d193e", "payment_of_dividends": "d2#F_d4cc006c-e100-44ed-a379-5c42c2858d98", "repurchase_of_common_stock": "d2#F_d9064a1c-09a3-4b4b-8494-ca58ed259a8c", "net_cash_from_financing_activities": "d2#F_949b125c-77d7-4946-b998-d29b4eafd074", "change_in_cash_and_cash_equivalents": "d2#F_c04f8ce6-1461-4b18-bcbe-60b5247b5622", "interest_payments": "d2#F_13f90980-8675-4ac8-8961-c2fbfbc29c4f", "income_tax_payments_net": "d2#F_cee3c781-eb25-48e2-854c-0b7c47c2893d", "free_cash_flow": "d2#F_9bf65ac0-0d80-4719-994a-e256c9727712" }, "operating_statistics": { "number_of_hospitals": "d2#F_c80656d4-1a81-415b-a392-fa71bcb59602" }, "prior_year_comparative": { "income_statement": { "revenues": "d2#F_39f4d86f-71ba-4982-a11c-f35752db1a08", "salaries_and_benefits": "d2#F_65d188d9-445e-4a34-be4b-216efd787ace", "supplies": "d2#F_17de68d9-3421-48d3-bfa7-fd0bc93ec2f9", "other_operating_expenses": "d2#F_cafbd47f-553d-42c9-9ff9-e33a1fbe8c62", "equity_in_earnings_of_affiliates": "d2#F_2b9c2a33-9032-40c9-a47d-3be45c26faa6", "depreciation_and_amortization": "d2#F_3c9bc880-8e50-4f39-9aa4-cf0300ccc99a", "interest_expense": "d2#F_68f1b05f-54b5-4c03-88f0-cc3a2fe89291", "losses_gains_on_sales_of_facilities": "d2#F_62be2bba-4a86-4319-8b61-243709fc93ec", "total_costs_and_expenses": "d2#F_853bccc4-fc52-4b53-82d1-62d4b9861c1c", "income_before_income_taxes": "d2#F_c79434b2-c8d3-4a48-9b02-ae473778d528", "provision_for_income_taxes": "d2#F_000614f1-cb33-4673-9887-cfbdb14bec83", "net_income": "d2#F_5c358934-4a14-43e9-95b9-07ebca18068c", "net_income_attributable_to_noncontrolling_interests": "d2#F_c4ee6a17-dab4-4ab0-9acb-c5f91a6bb715", "net_income_attributable_to_hca_healthcare": "d2#F_599981c8-144a-48fd-a525-85f14b8428a8", "basic_eps": "d2#F_9b6da7c2-0121-4aa2-9192-691fc2186b8a", "diluted_eps": "d2#F_270479bd-9fe0-4be0-9167-6ca919ed2430", "basic_shares": "d2#F_15cc86ca-6d83-43b1-a487-3d09b51290cc", "diluted_shares": "d2#F_66b60645-09d7-4e5c-9301-f4f84ccd1939" }, "cash_flow": { "operating_cash_flow": "d2#F_35666dba-a32a-426e-853d-1d679505a649", "depreciation_and_amortization": "d2#F_2c7cad2a-9c5a-474e-946c-dbf1e76eda31", "share_based_compensation": "d2#F_b481d03f-a50d-4064-b6c6-1c3811bd089c", "capital_expenditures": "d2#F_63e15c36-c18c-4dcd-949b-8044f50e3a54", "acquisitions_of_hospitals_and_health_care_entities": "d2#F_7d9c4862-fd82-443a-8416-e4c9e025d7ef", "sales_of_hospitals_and_health_care_entities": "d2#F_80ae328c-e2ba-4cff-9596-de4b4bbd0214", "net_cash_from_investing_activities": "d2#F_f5f3da43-0e27-455a-9233-0187da10059f", "issuances_of_long_term_debt": "d2#F_1c01c505-7a2d-49c0-a7c4-907dbcb11681", "net_change_in_short_term_borrowings_and_revolving_credit_facilities": "d2#F_1b63301c-832b-4c7a-b7ac-3f1b113f03f5", "repayment_of_long_term_debt": "d2#F_90aa566c-6b35-42d6-8193-a9cccceabf60", "distributions_to_noncontrolling_interests": "d2#F_bbd71103-68ff-43a2-b934-72e032d97a9c", "payment_of_dividends": "d2#F_bd9f8af6-c28d-465d-9786-d8387ace588b", "repurchase_of_common_stock": "d2#F_6366953a-6d50-4907-bdf2-b65adbb147f3", "net_cash_from_financing_activities": "d2#F_47c48e78-5d2e-4f61-85b4-7e081390df88", "change_in_cash_and_cash_equivalents": "d2#F_4d13cc27-232c-463e-9a69-8c1e28056603", "interest_payments": "d2#F_fb1ae213-0d66-47e2-8dbb-fb1f3496a560", "income_tax_payments_net": "d2#F_aa31e811-5e8b-43d0-8d9f-5a32a4fb1269" } } } } }